A nurses union is focusing the force of its 185,000 members against Hillary Clinton in the contest for Democratic nomination for president. (Daily Caller)
The FDA approved the imaging agent Netspot to detect neuroendocrine tumors.
And the EU approved everolimus (Afinitor) to treat certain lung and GI neuroendocrine tumors, following the FDA's approval in February.
Virginia now reports 18 cases of Zika infections, that's out of the roughly 600 cases nationwide. (Virginian Pilot)
This lone oncologist shepherded a new chemotherapy to clinical trial, and why it couldn't happen today. (STAT)
FDA drafted guidelines to target food with high sodium levels. (NPR) However, there's strong evidence against population wide sodium controls. (CardioBrief)
Coca Cola gave pediatricians branded prescription pads and health "diplomas" for kids. (Weighty Matters)
Here's why pediatric concussions might be vastly under-reported. (CBS)
Can you guess what causes pushed the death rate up in the U.S. for the first time in a decade? (The New York Times)
Some therapists discriminate against blacks and working class people, according to Princeton University study. (CNN)
When is it okay for oncologists use the word "cured"? (Bloomberg)
Forbes, which last year said Theranos founder Elizabeth Holmes was worth $4.5 billion, now values her holdings in the troubled diagnostics firm at "nothing."
Dermira said its topical drug for axillary hyperhidrosis (profuse underarm sweating, to your patients) succeeded in two phase III trials.
A generic form of wake-promoting drug armodafinil (Nuvigil) is now available in the U.S., says manufacturer Mylan.
The FDA has approved a blood test for EGFR mutations in non-small cell lung cancer to identify patients who might be candidates for treatment with erlotinib (Tarceva).
The 2015 results of MGMA's annual medical specialty salary surveys are out. (Forbes)
Virtual reality for analgesia? (Inside Science)
An inhaled COPD combo treatment is now accelerated for FDA filing by end of 2016, says manufacturer GlaxoSmithKline.
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.